BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 15703852)

  • 21. HIV controls the selective packaging of genomic, spliced viral and cellular RNAs into virions through different mechanisms.
    Houzet L; Paillart JC; Smagulova F; Maurel S; Morichaud Z; Marquet R; Mougel M
    Nucleic Acids Res; 2007; 35(8):2695-704. PubMed ID: 17426127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for preferential copackaging of Moloney murine leukemia virus genomic RNAs transcribed in the same chromosomal site.
    Kharytonchyk SA; Kireyeva AI; Osipovich AB; Fomin IK
    Retrovirology; 2005 Jan; 2():3. PubMed ID: 15656910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on bovine leukemia virus envelope glycoprotein gp30 YXXL sequences in virus infection and fusogenic activity].
    Inabe K
    Hokkaido Igaku Zasshi; 1998 May; 73(3):239-52. PubMed ID: 9719950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
    Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
    Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of bluetongue virus chimeric VP3 molecules and their interactions with VP7 protein to assemble into virus core-like particles.
    Tanaka S; Mikhailov M; Roy P
    Virology; 1995 Dec; 214(2):593-601. PubMed ID: 8553561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of internal sequences in the Moloney murine leukemia virus genome on replication].
    Fomin IK; Lobanova AB; Voĭtenok NN
    Genetika; 1995 Nov; 31(11):1490-7. PubMed ID: 8666218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
    Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
    Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capsid-targeted viral inactivation can eliminate the production of infectious murine leukemia virus in vitro.
    VanBrocklin M; Federspiel MJ
    Virology; 2000 Feb; 267(1):111-23. PubMed ID: 10648188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins.
    Hatziioannou T; Russell SJ; Cosset FL
    Virology; 2000 Feb; 267(1):49-57. PubMed ID: 10648182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complementarity between RNA dimerization elements favors formation of functional heterozygous murine leukemia viruses.
    Rasmussen S; Pedersen FS
    Virology; 2004 Nov; 329(2):440-53. PubMed ID: 15518822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA.
    Certo JL; Kabdulov TO; Paulson ML; Anderson JA; Hu WS
    J Virol; 1999 Nov; 73(11):9170-7. PubMed ID: 10516024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A small and efficient dimerization/packaging signal of rat VL30 RNA and its use in murine leukemia virus-VL30-derived vectors for gene transfer.
    Torrent C; Gabus C; Darlix JL
    J Virol; 1994 Feb; 68(2):661-7. PubMed ID: 8289369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of different culture conditions on BLV expression in permanently infected FLK cell lines.
    Rössler H; Burkhardt H; Rosenthal S; Scholz D; Rosenthal HA; Altaner C
    Folia Biol (Praha); 1985; 31(4):273-83. PubMed ID: 2412904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence polymorphisms in the long terminal repeat of bovine leukemia virus: evidence for selection pressures in regulatory sequences.
    Zhao X; Jimenez C; Sentsui H; Buehring GC
    Virus Res; 2007 Mar; 124(1-2):113-24. PubMed ID: 17123656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Structural organization and intravirion interactions of proteins of the bovine leukemia virus].
    Eremin VF
    Eksp Onkol; 1989; 11(4):3-9. PubMed ID: 2474432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudotype-independent nonspecific uptake of gammaretroviral and lentiviral particles in human cells.
    Voelkel C; Galla M; Dannhauser PN; Maetzig T; Sodeik B; Schambach A; Baum C
    Hum Gene Ther; 2012 Mar; 23(3):274-86. PubMed ID: 22010882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A murine leukemia virus derived retroviral vector with a rat VL30 packaging psi sequence.
    Torrent C; Wang P; Darlix JL
    Bone Marrow Transplant; 1992; 9 Suppl 1():143-7. PubMed ID: 1324044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How retroviruses select their genomes.
    D'Souza V; Summers MF
    Nat Rev Microbiol; 2005 Aug; 3(8):643-55. PubMed ID: 16064056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The YXXL sequences of a transmembrane protein of bovine leukemia virus are required for viral entry and incorporation of viral envelope protein into virions.
    Inabe K; Nishizawa M; Tajima S; Ikuta K; Aida Y
    J Virol; 1999 Feb; 73(2):1293-301. PubMed ID: 9882334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infectious particles derived from Semliki Forest virus vectors encoding murine leukemia virus envelopes.
    Lebedeva I; Fujita K; Nihrane A; Silver J
    J Virol; 1997 Sep; 71(9):7061-7. PubMed ID: 9261436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.